Rejected at 9:58 p.m. Jan, 06, 2026 ] by gnigam
Author: ishwarm
Related Note: 1510190580072 4
Rationale for change

Increasing rates of resistance to trimethoprim in E. Coli have resulted in nitrofurantoin taking on a larger role in therapy. AMBOSS supports this and it is further confirmed by StatPearls:

https://www.ncbi.nlm.nih.gov/books/NBK470526/

Current therapy for an E. Coli UTI begins with nitrofurantoin
Source: AMBOSS - https://next.amboss.com/us/article/7i04Gf?q=nitrofurantoin+urinary+tract+infections+%28utis%29&v=overview#Zc27d78347d45b1423debf25ad883dd4c

Rejection reason

https://next.amboss.com/us/article/Sn0ysg?q=e%20coli%20uti#Z2018b58c3c7835457287264e40fa1a3c
The link you attached shows that it is an empiric treatment. But this link shows that TMPSMX and cipro are preffered if E coli is known to be causative

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#SketchyMicro::01_Bacteria::05_Gram_(-)_Bacilli_-_Enteric_Tract::05_Escherichia_coli_(ETEC,_EHEC) #PANCE::EOR::PEDS #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::03_GU_Infections::02_Cystitis,_Pyelonephritis,_Prostatitis_Management #AK_Step1_v12::#Bootcamp::Microbiology::10_Lactose_Fermenting_Gram_Negative_Bacilli::02_Variant_Strains_of_Escherichia_Coli #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::19_Diaminopyrimidines_and_Sulfonamides #AK_Step1_v12::#NinjaNerd::03_Microbiology::04_Pharmacology::05_Antibiotics_(Folic_Acid_Pathway_Inhibitors:_Part_2) #AK_Step1_v12::#Physeo::06_Micro::02_Bacteria::30_E._Coli #AK_Step1_v12::#Bootcamp::Microbiology::10_Lactose_Fermenting_Gram_Negative_Bacilli::01_Escherichia_Coli #AK_Step1_v12::#FirstAid::03_Microbiology::02_Clinical_Bacteriology::33_Escherichia_coli #AK_Step2_v12::#SketchyFM::01_Acute_Presentations::08_Genitourinary_Symptoms::01_Approach_To_Dysuria #AK_Other::Only_Step_1 #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::04_Gram_Negative_Rods::Extra #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::04_Other_Antibiotics::01_Trimethoprim/Sulfamethoxazole #PANCE::EOR::Family_med #AK_Step1_v12::#Bootcamp::Nephrology::13_Inflammatory_Conditions_&_Malignancy::01_Acute_Cystitis #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease #AK_Step2_v12::#B&B::08_Infectious_Disease::01_Antibiotics::04_Other_Antibiotics::Extra